Bio Essence Corp (BIOE)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 600K 1.2M 1.8M Q4 '20: 218.9K Q1 '21: 212K Q2 '21: 235.9K Q3 '21: 227K Q4 '21: 213K Q1 '22: 306.4K Q2 '22: 288.1K Q3 '22: 192.1K Q1 '23: 341.3K Q2 '23: 259.6K Q3 '23: 155.7K Q2 '24: 41.7K Q3 '24: 134.7K Q4 '24: 147.6K Q1 '25: 22.2K Q2 '25: 259.1K Q3 '25: 136.8K Q4 '25: 1.5M Q1 '26: 500.5K Q2 '26: 794.7K Q1 '21 Q4 '21 Q3 '22 Q3 '23 Q4 '24 Q3 '25 Q2 '26

Gross Profit Quarterly

0 400K 800K 1.2M Q1 '21: 76.7K Q2 '21: 64.5K Q3 '21: 95.4K Q4 '21: 61.7K Q1 '22: 70.5K Q2 '22: 157.3K Q3 '22: 86.5K Q4 '22: 14K Q1 '23: 166.5K Q2 '23: 109.7K Q3 '23: 20.2K Q2 '24: 29.2K Q3 '24: 81K Q4 '24: 106.9K Q1 '25: 20.6K Q2 '25: 168.6K Q3 '25: 95.8K Q4 '25: 1.1M Q1 '26: 319.4K Q2 '26: 470.3K Q2 '21 Q1 '22 Q4 '22 Q3 '23 Q4 '24 Q3 '25 Q2 '26

Operating Income Quarterly

-400K 0 400K 800K 1.2M Q3 '21: -192.9K Q4 '21: -198.8K Q1 '22: -226.4K Q2 '22: -155.9K Q3 '22: -192.6K Q4 '22: 63.8K Q1 '23: -24.3K Q2 '23: -43.2K Q3 '23: -82.6K Q4 '23: -195.5K Q1 '24: -151.8K Q2 '24: -165K Q3 '24: -146.4K Q4 '24: 3.9K Q1 '25: -205.1K Q2 '25: 61.2K Q3 '25: 14.3K Q4 '25: 1M Q1 '26: 215.8K Q2 '26: 279.3K Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income Quarterly

-1.5M -1M -500K 0 500K 1M 1.5M Q3 '21: -183K Q4 '21: -90.6K Q1 '22: -233.1K Q2 '22: -164.2K Q3 '22: -199.2K Q4 '22: -213.1K Q1 '23: -178.8K Q2 '23: -284.5K Q3 '23: -314.8K Q4 '23: -193.7K Q1 '24: 133.9K Q2 '24: -215.7K Q3 '24: -1.2M Q4 '24: -27.6K Q1 '25: -205.8K Q2 '25: 59.9K Q3 '25: 13K Q4 '25: 1M Q1 '26: 205.4K Q2 '26: 270.1K Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue Quarterly

0 150K 300K 450K Q4 '20: 281K Q1 '21: 135.3K Q2 '21: 171.4K Q3 '21: 131.6K Q4 '21: 151.3K Q1 '22: 236K Q2 '22: 130.8K Q3 '22: 105.5K Q1 '23: 174.8K Q2 '23: 149.9K Q3 '23: 135.4K Q2 '24: 12.5K Q3 '24: 53.7K Q4 '24: 40.7K Q1 '25: 1.6K Q2 '25: 90.5K Q3 '25: 41K Q4 '25: 336K Q1 '26: 181.2K Q2 '26: 324.4K Q1 '21 Q4 '21 Q3 '22 Q3 '23 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow Quarterly

-500K 0 500K 1M 1.5M Q3 '21: -173.1K Q4 '21: -142.6K Q1 '22: -254.5K Q2 '22: -189.2K Q3 '22: -130.3K Q4 '22: -129.3K Q1 '23: -231.7K Q2 '23: -245K Q3 '23: -344.8K Q4 '23: -204.1K Q1 '24: -171.6K Q2 '24: 15.3K Q3 '24: 357.1K Q4 '24: 423.1K Q1 '25: -26.1K Q2 '25: 167.8K Q3 '25: 187K Q4 '25: 1.2M Q1 '26: -412K Q2 '26: 59.6K Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

-900K -600K -300K 0 300K 600K 900K Q4 '20: -242.5K Q1 '21: -168.2K Q2 '21: -830.9K Q3 '21: -182.1K Q4 '21: -232.4K Q3 '22: -182.3K Q4 '22: -134.8K Q4 '23: -204.1K Q4 '20 Q1 '21 Q2 '21 Q3 '21 Q4 '21 Q3 '22 Q4 '22 Q4 '23

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 20M 40M 60M Q1 '21: 33M Q2 '21: 33M Q3 '21: 33M Q1 '22: 33M Q2 '22: 33M Q3 '22: 33M Q1 '23: 33M Q2 '23: 34.7M Q3 '23: 38M Q1 '24: 38M Q2 '24: 38M Q3 '24: 38M Q1 '25: 38M Q2 '25: 38M Q3 '25: 38M Q1 '26: 45M Q2 '26: 50.9M Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.06 -0.04 -0.02 0.00 0.02 0.04 0.06 Q4 '20: -0.02 Q1 '21: -0.03 Q2 '21: -0.02 Q3 '21: -0.02 Q4 '21: -0.02 Q1 '22: -0.02 Q2 '22: -0.02 Q3 '22: -0.02 Q4 '22: -0.02 Q1 '23: -0.02 Q2 '23: -0.03 Q3 '23: -0.03 Q4 '23: -0.04 Q1 '24: -0.03 Q2 '24: -0.03 Q3 '24: -0.05 Q4 '24: -0.04 Q1 '25: -0.05 Q2 '25: -0.04 Q4 '20 Q3 '21 Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.